Co-Q10 And Cancer
Heart
disease. Cancer. AIDS. As unbelievable as it might sound,
each of these deadly diseases often responds to a coenzyme
Q10, a little known nutrient that can make a big difference
in your health.
Granted,
such "cure all" statements leave people wondering
whether CoQ10 is just the latest panacea of the month. Rest
assured: the benefits of this nutrient are well documented
in the medical journals. It's one of the most frequently
prescribed heart "drugs" in Japan and widely used
in Europe-and one company even owns the patent for the CoQ10
treatment of AIDS.
Ask
your doctor about CoQ10, though, and he'll probably say
he's never heard of it. Part of the problem is CoQ10's name.
"Most doctors don't know what a coenzyme is,"
said Karl Folkers, Ph.D., one of the researchers who pioneered
CoQ10. Most biochemists know it as ubiquinone, an equally
arcane name.
CoQ10
is a little easier to appreciate when you remember that
vitamins function as co-enzymes in the body, furthering
thousands of essential biochemical reactions. CoQ10's key
role is in producing adenosine triphosphate (ATP), needed
for energy production in every cell of the body. Secondary
to that, CoQ10 functions as a powerful antioxidant.
This
vitamin-like nutrient occurs widely in the food supply,
though not always in significant amounts. In addition, each
cell in the body manufactures CoQ10, though not always very
efficiently. That means you may not be getting enough for
optimal health.
"Like
the vitamins discovered in the early part of this century,
CoQ10 is an essential element of food that can now be used
medicinally," explained Peter Langsjoen, M.D., a cardiologist
in Tyler, Texas.
CoQ10
and the Heart
CoQ10
was discovered in 1957-relatively late as vitamins discoveries
go-by Frederick Crane, Ph.D., now at Purdue University in
Indiana. Four years later, Peter D. Mitchell, Ph.D., of
the University of Edinburgh, figured out how CoQ10 produces
energy at the cellular level and, in 1978, won the Nobel
Prize for chemistry for this discovery.
By
the mid-1960s, Japanese researchers recognized that CoQ10
concentrated in the myocardium, or heart muscle. Its role
in the heart makes sense: the heart, one of the body's most
energetic organs, beats approximately 100,000 times a day
and 36 million times a year, and depends on CoQ10 for "bioenergetics."
In the early 1980s, Folkers, director of the Institute for
Biochemical Research at the University of Texas, and the
late Per H. Langsjoen, M.D. (Peter's father), conducted
the first study of CoQ10 in the treatment of cardiomyopathy,
a form of progressive heart failure.
The
findings were astounding. In a well-controlled study, 19
patients who were expected to die from heart failure rebounded
with an "extraordinary clinical improvement,"
according to Folkers and Langsjoen's report in the Proceedings
of the National Academy of Sciences of the USA (June 1985;82:4240-4).
Case
studies demonstrate the dramatic effect of CoQ10. In Biochemical
and Biophysical Research Communications (Jan 15, 1993;182:247-53),
Folkers described a 43-year-old man suffering from cardiomyopathy.
After being given CoQ10, his enlarged heart became smaller
(indicating it was working more efficiently), and he was
able to resume an "extremely active athletic lifestyle."
The heart function of another patient, a 50-year-old man
with very severe cardiomyopathy, returned after he took
CoQ10, and he has since had "no limitations of activity."
Numerous
other studies have confirmed the role of CoQ10 in treating
heart failure, which is otherwise treated with drugs (such
as beta blockers and ACE inhibitors)-or with a heart transplant.
A sampling:
* Sixty-five cardiologists treating 806 patients for heart
failure or ischemic heart disease indicated "significant"
benefits from CoQ10. (Langsjoen, PH, Klinische Wochenschrift,
1988;66:583-90.)
* Twenty-five hundred heart failure patients at 173 Italian
medical centers were given 50 to 150 mg CoQ10 daily for
three months. Eighty percent of the patients had some type
of improvement. (Clinical Investigator, Aug. 1993;71S:145-9)
* A 12-month double-blind study compared 319 patients taking
CoQ10 with 322 taking a placebo. CoQ10 reduced complications
of heart failure as well as the need for hospitalization.
(Clinical Investigator, Aug. 1993;71S:134-6).
CoQ10 and Cancer
Although
CoQ10 is best documented in the treatment of heart failure,
two recent medical journal articles suggest tremendous promise
in the treatment of cancer. In Biochemical and Biophysical
Research Communications (April 15, 1993;192:241-5), Folkers
described 10 cancer patients given CoQ10 for heart failure.
One of the patients, a 48-year-old man diagnosed in 1977
with inoperable lung cancer, has been not had any signs
of either cancer and heart failure symptoms while taking
CoQ10 for 17 years! Another patient, an 82-year-old man,
had been treated for colon cancer.
Knud
Lockwood, M.D., a cancer specialist in Copenhagen, Denmark,
recently described his treatment of 32 "high-risk"
breast cancer patients with antioxidant vitamins, essential
fatty acids, and CoQ10. "No patient died and all expressed
a feeling of well-being," he wrote in Biochemical and
Biophysical Research Communications (March 30, 1994;199:1504-8).
"These clinical results are remarkable since about
4 deaths would have been expected. Now, after 24 months,
all still survive; about 6 deaths would have been expected."
Six
of the 32 patients showed partial tumor remission, and two
benefited from very high doses of CoQ10. One, a 59-year-old
woman with a family history of breast cancer, had a tumor
removed from her left breast. The cancer returned, but "stabilized"
at about 1.5-2 centimeters (about 1/2 to 3/4-inch) in diameter
when the patient took 90 mg. of CoQ10 daily. One month after
increasing the CoQ10 intake to 390 mg. daily, the tumor
disappeared. Mammography confirmed its absence.
Another
patient, age 74, had a small tumor removed from her right
breast. She refused a second operation to remove additional
growths and began taking 300 mg of CoQ10 daily. Three months
later, an examination and mammography revealed no evidence
of the tumor or metastases.
Lockwood,
who has treated some 7,000 cases of breast cancer over 35
years, wrote that until using CoQ10, he had "never
seen a spontaneous complete regression of a 1.5-2.0 centimeter
breast tumor, and has never seen a comparable regression
on any conventional anti-tumor therapy."
CoQ10
and AIDS
One
of the most remarkable findings was that CoQ10 supplementation
could extend the lifespan of patients with acquired immune
deficiency syndrome (AIDS). In 1986, Folkers and Per Langsjoen
began treating seven patients with HIV or AIDS. Not all
of the patients consistently took CoQ10, but "the treatment
was very encouraging and at times even striking," Folkers
wrote in Biochemical and Biophysical Research Communications
(June 16, 1988;153:888-96). "All 7 patients (3 AIDS,
4 ARC) felt better soon after starting on CoQ10," wrote
Folkers.
It's
with the treatment of AIDS that the medical story of CoQ10
turns into one of economic intrigue. The University of Texas,
where the AIDS/CoQ10 research was conducted, applied for
a "use-patent" for the treatment of AIDS. The
patent (#1,011,858), one of several for CoQ10 and immune
function, was granted on April 30, 1991. The use-patent
gives the owner full patent rights to the nutrient when
it's prescribed for the treatment of AIDS.
In
1993, the university sold the use-patient to James Ryan,
an investment banker and one of the patients in Folkers'
original cardiomyopathy study. Ryan, head of Ryan Pharmaceuticals,
paid several hundred thousand dollars for the use patent,
then sold it for an estimated $2 million to Receptagen,
a U.S./Canadian biotechnology firm. The company plans to
market prescription versions of CoQ10 for the treatment
of AIDS sometime in the next two years.
How
Much To Take?
So
is CoQ10 a drug or a nutrient? Studies of patients with
heart disease, cancer, and AIDS indicate that they are routinely
deficient in CoQ10. Although CoQ10 is found in many foods,
only organ meats contain significant amounts-but most people
do not eat these foods. Can the body make up the difference?
Folkers is doubtful. He recently observed that "many
Americans do not have adequate levels of all the vitamins,
coenzymes and trace elements for the multi-step biosynthesis
of CoQ10 even for limited health and survival apart from
optimum health and survival."
So
if CoQ10 so good, why don't more doctors use it? Peter Langsjoen,
M.D., recently ventured an explanation.
"The
answer to this question is found in the fields of politics
and marketing and not in the fields of science or medicine.
The controversy surrounding CoQ10 likewise is political
and economic, as the previous 30 years of research on CoQ10
have been remarkably consistent and free of major controversy,"
he explained.
"Although
it is not the first time that a fundamental and clinically
important discovery has come about without the backing of
a pharmaceutical company, it is the first such discovery
to so radically alter how physicians must view disease.
While the pharmaceutical industry does a good job at physician
and patient education on their new products, the distributors
of CoQ10 are not as effective at this."
Therapeutic
dosages of CoQ10 for serious diseases range from 200-400
mg. daily, ideally under a physician's supervision. It works
in diverse conditions because the basic underlying mechanisms
are the same-energy production at the cellular level and
antioxidant protection against free radicals. In an interview,
Folkers said that CoQ10 is safe and has no negative side
effects, though it may decrease the need for other heart
medicines. A common preventive dose ranges from 10-30 mg
daily.
The information provided by Jack Challem and The Nutrition
Reporter™ newsletter is strictly educational and not intended
as medical advice. For diagnosis and treatment, consult
your physician. And in case you were wondering, neither
Jack Challem nor The Nutrition Reporter™ sell vitamins.
Angstrom Minerals Product And Price List
The information on this page has been extracted from http://www.thenutritionreporter.com/CoenzymeQ10.html